Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irwin Davidson

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Elife|March 25, 2015
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cellsPatrick Laurette, Thomas Strub, Dana Koludrovic, et al.
Genome Biology|January 5, 2021
Comprehensive integrative profiling of upper tract urothelial carcinomasXiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, et al.
Molecular and Cellular Biology|February 1, 2012
Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferationIrina Berlin, Laurence Denat, Anne-Lise Steunou, et al.
Cancers|July 2, 2021
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine TumorsVéronique Debien, Guillaume Davidson, Philippe Baltzinger, et al.
EMBO Reports|July 23, 2021
CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanomaPietro Berico, Max Cigrang, Guillaume Davidson, et al.
American Journal of Human Genetics|March 5, 2017
Hypomorphic Pathogenic Variants in TAF13 Are Associated with Autosomal-Recessive Intellectual Disability and MicrocephalyHasan Tawamie, Igor Martianov, Natalie Wohlfahrt, et al.
Development (Cambridge, England)|December 23, 2011
Cdx2 determines the fate of postnatal intestinal endodermEmma J Stringer, Isabelle Duluc, Thoueiba Saandi, et al.
EMBO Molecular Medicine|March 28, 2025
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinomaAlexandra Helleux, Guillaume Davidson, Antonin Lallement, et al.
Nature Communications|November 24, 2015
TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activationFederica Ferri, Aude Parcelier, Vanessa Petit, et al.
The Oncologist|March 12, 2022
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint InhibitorsJustine Gantzer, Guillaume Davidson, Bujamin Vokshi, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Elife|March 25, 2015
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cellsPatrick Laurette, Thomas Strub, Dana Koludrovic, et al.
Genome Biology|January 5, 2021
Comprehensive integrative profiling of upper tract urothelial carcinomasXiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, et al.
Molecular and Cellular Biology|February 1, 2012
Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferationIrina Berlin, Laurence Denat, Anne-Lise Steunou, et al.
Cancers|July 2, 2021
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine TumorsVéronique Debien, Guillaume Davidson, Philippe Baltzinger, et al.
EMBO Reports|July 23, 2021
CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanomaPietro Berico, Max Cigrang, Guillaume Davidson, et al.
American Journal of Human Genetics|March 5, 2017
Hypomorphic Pathogenic Variants in TAF13 Are Associated with Autosomal-Recessive Intellectual Disability and MicrocephalyHasan Tawamie, Igor Martianov, Natalie Wohlfahrt, et al.
Development (Cambridge, England)|December 23, 2011
Cdx2 determines the fate of postnatal intestinal endodermEmma J Stringer, Isabelle Duluc, Thoueiba Saandi, et al.
EMBO Molecular Medicine|March 28, 2025
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinomaAlexandra Helleux, Guillaume Davidson, Antonin Lallement, et al.
Nature Communications|November 24, 2015
TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activationFederica Ferri, Aude Parcelier, Vanessa Petit, et al.
The Oncologist|March 12, 2022
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint InhibitorsJustine Gantzer, Guillaume Davidson, Bujamin Vokshi, et al.
Pageof 13